BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17121985)

  • 1. Activation of an oncogenic microRNA cistron by provirus integration.
    Wang CL; Wang BB; Bartha G; Li L; Channa N; Klinger M; Killeen N; Wabl M
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18680-4. PubMed ID: 17121985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mml1, a new common integration site in murine leukemia virus-induced promonocytic leukemias maps to mouse chromosome 10.
    Koller R; Krall M; Mock B; Bies J; Nazarov V; Wolff L
    Virology; 1996 Oct; 224(1):224-34. PubMed ID: 8862417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rmcf2, a xenotropic provirus in the Asian mouse species Mus castaneus, blocks infection by polytropic mouse gammaretroviruses.
    Wu T; Yan Y; Kozak CA
    J Virol; 2005 Aug; 79(15):9677-84. PubMed ID: 16014929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair.
    Nielsen AA; Sørensen AB; Schmidt J; Pedersen FS
    J Virol; 2005 Jan; 79(1):67-78. PubMed ID: 15596802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased virus population diversity in p53-null mice infected with weakly oncogenic Abelson virus.
    Marchlik E; Kalman R; Rosenberg N
    J Virol; 2005 Sep; 79(18):11618-26. PubMed ID: 16140739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
    Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
    Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
    Amtoft HW; Sørensen AB; Bareil C; Schmidt J; Luz A; Pedersen FS
    J Virol; 1997 Jul; 71(7):5080-7. PubMed ID: 9188573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies.
    Largaespada DA
    Leukemia; 2000 Jul; 14(7):1174-84. PubMed ID: 10914539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sint1, a common integration site in SL3-3-induced T-cell lymphomas, harbors a putative proto-oncogene with homology to the septin gene family.
    Sørensen AB; Lund AH; Ethelberg S; Copeland NG; Jenkins NA; Pedersen FS
    J Virol; 2000 Mar; 74(5):2161-8. PubMed ID: 10666245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation leukemia virus common integration at the Kis2 locus: simultaneous overexpression of a novel noncoding RNA and of the proximal Phf6 gene.
    Landais S; Quantin R; Rassart E
    J Virol; 2005 Sep; 79(17):11443-56. PubMed ID: 16103195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
    Kapoun AM; Shackleford GM
    Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gris1, a new common integration site in Graffi murine leukemia virus-induced leukemias: overexpression of a truncated cyclin D2 due to alternative splicing.
    Denicourt C; Kozak CA; Rassart E
    J Virol; 2003 Jan; 77(1):37-44. PubMed ID: 12477808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus.
    Glud SZ; Sørensen AB; Andrulis M; Wang B; Kondo E; Jessen R; Krenacs L; Stelkovics E; Wabl M; Serfling E; Palmetshofer A; Pedersen FS
    Blood; 2005 Nov; 106(10):3546-52. PubMed ID: 16051745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F-MuLV acceleration of myelomonocytic tumorigenesis in SV40 large T antigen transgenic mice is accompanied by retroviral insertion at Fli1 and a novel locus, Fim4.
    Kone J; Arroyo J; Savinelli T; Lin S; Boyd K; Wu Y; Nimmakayalu M; Copeland NG; Jenkins NA; Qumsiyeh M; Hu P; Prescott A; Wu H; Yang L; Roe B; Perkins AS
    Leukemia; 2002 Sep; 16(9):1827-34. PubMed ID: 12200699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of retrovirus-induced oncogenesis.
    Sourvinos G; Tsatsanis C; Spandidos DA
    Folia Biol (Praha); 2000; 46(6):226-32. PubMed ID: 11140855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of reversions and suppressors of a mutation in the CBF binding site of a lymphomagenic retrovirus.
    Martiney MJ; Rulli K; Beaty R; Levy LS; Lenz J
    J Virol; 1999 Sep; 73(9):7599-606. PubMed ID: 10438850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological characterization and molecular cloning of murine C-type retroviruses derived from the TSZ complex from mainland China.
    Bundy LM; Ru M; Zheng BF; Cheng L; Pattengale PK; Portis JL; Fan H
    Virology; 1995 Oct; 212(2):367-82. PubMed ID: 7571406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic profile of insertion mutations in mouse leukemias and lymphomas.
    Hansen GM; Skapura D; Justice MJ
    Genome Res; 2000 Feb; 10(2):237-43. PubMed ID: 10673281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Operating under a Gag order: a block against incoming virus by the Fv1 gene.
    Goff SP
    Cell; 1996 Sep; 86(5):691-3. PubMed ID: 8797814
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor model-specific proviral insertional mutagenesis of the Fos/Jdp2/Batf locus.
    Rasmussen MH; Sørensen AB; Morris DW; Dutra JC; Engelhard EK; Wang CL; Schmidt J; Pedersen FS
    Virology; 2005 Jul; 337(2):353-64. PubMed ID: 15913695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.